MedTrace Logo

Efficacy-Implementation Study for PC CARES in Rural Alaska

NCT06658808 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1075

Last updated 2025-06-15

No results posted yet for this study

Summary

This participatory, pragmatic efficacy-implementation trial evaluates the impact of Promoting Community Conversations About Research to End Suicide (PC CARES) to evaluate Learning Circle (LC) participant outcomes (AIM#1), community-wide diffusion effects, and efficacy by tracking youth impact (AIM#2), while finding sustainable ways to scale PC CARES to other Alaska Native (AN) communities (AIM#3).

Conditions

  • Suicide Prevention

Interventions

BEHAVIORAL

Promoting Community Conversations About Research to End Suicide

Promoting Community Conversations About Research to End Suicide (PC CARES) trains local community health workers to facilitate a series of five 3-hour Learning Circles (LCs) over \~6 months to develop a 'community of practice' (CoP), whereby trusted adults of youth (a) learn about SPBPs; (b) tailor the SPBPs to their culture and community; (c) build cross-sector relationships (parents, teachers, etc.), and (d) do more to prevent suicide. Each session shares evidence-based, actionable ways to enhance social support, reduce harm/risk, and promote help seeking, which participants adapt and apply in their daily interactions with youth.

Sponsors & Collaborators

  • Yukon Kuskokwim Health Corporation

    collaborator OTHER

  • Norton Sound Health Corporation

    collaborator OTHER

  • Maniilaq Association

    collaborator UNKNOWN

  • University of Alaska Fairbanks

    collaborator OTHER

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of Michigan

    lead OTHER

Principal Investigators

  • Lisa Wexler, PhD · Univer

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-12
Primary Completion
2029-12-31
Completion
2031-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06658808 on ClinicalTrials.gov